U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 10 results

Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2014)
First approved in 2014

Class (Stereo):
CHEMICAL (ACHIRAL)



Miltefosine is an anti-leishmanial agent. It is an alkyl phospholipids compound, was originally intended for breast cancer and other solid tumors. However, it could not be developed as an oral agent because of dose-limiting gastro-intestinal toxicity...
Status:
Possibly Marketed Outside US
First approved in 2022

Class (Stereo):
CHEMICAL (ABSOLUTE)



Sesamin is the most prominent lignan compound found in sesame seeds, one of the two highest sources of lignans in the human diet (the other being flax). Sesamin is catered to be a nutritional supplement that confers antioxidant and antiinflammatory e...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
US Approved Rx (2024)
First approved in 2015

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ivabradine (CORLANOR®) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker that reduces the spontaneous pacemaker activity of the cardiac sinus node by selectively inhibiting the If-current, resulting in heart rate reduction at c...
Status:
Possibly Marketed Outside US
First approved in 2022

Class (Stereo):
CHEMICAL (RACEMIC)



Sesamin is the most prominent lignan compound found in sesame seeds, one of the two highest sources of lignans in the human diet (the other being flax). Sesamin is catered to be a nutritional supplement that confers antioxidant and antiinflammatory e...